Genome-wide disease association analysis by using SNPs is being explored as a method for dissecting complex genetic traits (Risch and Merikangas 1996) , and a vast number of SNPs have been generated for this purpose. As there are cost and throughput limitations of genotyping large numbers of SNPs and statistical issues regarding the large number of dependent tests on the same data set, to make association analysis practical it has been proposed that SNPs should be prioritized based on likely functional importance (Risch 2000) . The most easily identi®able functional SNPs are coding SNPs (cSNPs), and accordingly cSNPs have been screened in a number of studies (Cargill et al. 1999; Halushka et al. 1999) . SNPs in gene regulatory sequences embedded in noncoding DNA are another class of SNPs suggested for prioritization owing to their predicted quantitative impact on gene expression. The main challenge in evaluating these SNPs, in contrast to cSNPs, is a lack of robust algorithms and databases for recognizing regulatory sequences in noncoding DNA. Approaches that have been previously used to delineate noncoding sequences with gene regulatory activity include crossspecies sequence comparisons and the search for sequences recognized by transcription factors (Gottgens et al. 2000; Loots et al. 2000) . We combined these two methods to sift through mouse human genomic sequences to identify putative gene regulatory elements and subsequently localized SNPs within these sequences in a 1-Megabase (Mb) region of human Chromosome (Chr) 5q31, orthologous to mouse Chr 11 containing the Interleukin cluster (Fig. 1a) .
To survey SNPs in conserved noncoding sequences (CNS), we screened 40 individuals of European (n = 23) and African (n =17) origin. A CNS was selected by cross-species sequence alignments with an inclusion criterion of ³80% identity over ³120bp by intersection/union analyses of a 200-kb region of this interval (Dubchak et al. 2000) . CNS (n = 52) meeting these criteria (Fig. 1a) were screened, and of these CNS1 , CNS 7 (Cockerill et al. 1999) , CNS23 (Cockerill et al. 1999) , CNS2 and CNS17 (G.G. Loots personal communication) have been experimentally veri®ed as gene regulatory elements. In addition to the CNS, two genes in the interval, IL3 and CSF2, were also sequenced, and we obtained a total of 85 SNPs, of which 28 were located in the CNS. Characteristics of the SNPs, categorized by location in coding, non-coding, CNS or intergenic sequences are provided in Table 1a .
For a comparative study of sequence diversity, in this 1-Mb region, we estimated the average heterozygosity (H) and the segregating sites parameter (h S ). Under the assumptions of neutrality, Hardy-Weinberg equilibrium (HWE) and a mutation model that assumes only one mutation at each bp, (known as the in®nite sites model) (Li 1997 ), h S is also an estimator of the mutation rate. The total levels of nucleotide diversity (Table 1a) in this 1-Mb region are consistent with those observed in previous studies (Halushka et al. 1999; Sunyaev et al. 2000) . SNPs were found at a similar frequency of 1 per 494 bp in coding sequences with h S = 4.09´10
)4 , and 1 per 403 bp in the CNS with h S = 5.01´10 . The similar values of average heterozygosity (H) and the theta estimator derived from the segregating sites for the various classes of SNPs (Table 1a) indicate that the standard neutral model is applicable over this region as a whole. However, this does not preclude selection acting on parts of this genomic region, such as the exons of CSF2. Since in this sample there are few SNPs within these genes, there is a lack of power to detect departures from neutrality by statistical tests based on summary measures such as the average heterozygosity and h S based merely on sequence data, i.e., non-phased data.
Allele frequencies at SNPs have implications for the sample size required for disease association studies and are important in de®ning population sub-structures as well. The frequency spectra of the minor allele for the SNPs are shown in Fig. 1b . The frequency distribution of SNPs speci®c to individuals of African (41) and Northern European (14) descent, as well as the ones shared (30), is also depicted in Fig. 1b . The African samples produced more SNPs than the Northern European samples, and this is also re¯ected in the estimates of nucleotide diversity (Table 1b) , across all categories. Our results agree with previous studies and demonstrate greater diversity and more unique SNPs in the African population.
The two samples were tested for dierences between the two populations by using the two summary measures, H and h S , by using a permutation test. Accurate empirical distributions using two sample t-test-like statistics for both estimators were generated with 5000 random permutations of the data of a possible 1.52´10 11 permutations. The t-statistic based on h S was not a useful discriminant between the two populations, resulting in a spiky, multimodal empirical distribution for the statistic. Table 1a contains the p-values generated for the statistics based on the average heterozygosity. After adjustment for multiple testing (Bonferroni correction, 10 tests) the threshold for signi®cance for a single test becomes p = 0.005. As expected, exons showed no discernible dierences between the two samples; however, CNS regions showed a signi®cant dierence.
Linkage Disequilibrium (LD) was examined for the region by taking advantage of the Expectation-Maximization (EM) algorithm implemented as a permutation test in the software ARLEQUIN (Schneider et al. 2000) . LD can be estimated only from haplotype data. The EM algorithm (Slatkin and Excof®er, 1996) allows the estimation of haplotypes and their frequencies, thus providing an opportunity to examine LD with sequence data. Details of the procedure can be found in the ARLEQUIN manual. The LD was examined for the combined data from both populations by using a sliding window approach within pairs of SNPs so that each SNP overlapped with another. Thus, each test window was moved along by one SNP, and the next pair of SNPs was tested for LD; e.g., the ®rst data point on Fig. 1c is the LD between the ®rst SNP pair (SNP pair 1 and 2), whereas the second data point is the LD between the second SNP pair (SNP pair 2 and 3), and this sequence was employed for all SNPs to determine LD across the region. In this sample of Northern Europeans and Africans, high LD was observed around the coding regions, AF5Q31, Cyclin1-homolog, IL4, and IL3, with the highest around the SEPT8 gene (Fig. 1c) .
Population-speci®c SNPs in general have an inverse-J shaped distribution with the majority of sites (96%) having a minor allele frequency of less than 10%. Under the assumption that these SNPs have arisen only once and that they are neutral, these low frequencies would indicate the relative youth of these polymorphisms. The average allele frequency (minor allele) for population-speci®c SNPs is 3.3%, while that for shared SNPs is 30.4%. SNPs in CNS are uncommon, with 54% having a minor allele frequency less than 10%.
To further prioritize SNPs present in CNS, we ascertained sites that fall in predicted transcription factor binding sites (TFBS) conserved between mice and humans. Our method employed a computational tool, rVISTA, for high-throughput discovery of cis-regulatory elements that combines clustering of predicted TFBS and the analysis of inter-species sequence conservation to maximize the identi®cation of functional sites (Loots et al. 2002) . The potential of rVISTA to identify true positive TFBS while reducing the prediction of false positives was analyzed across this 1-Mb sequence by using a number of AP-1, NFAT, and GATA-3 sites that have been experimentally veri®ed. By employing the orthologous human±mouse dataset, >95% of the~58,000 TFBS predicted on the human sequence were eliminated, and rVISTA identi®ed 88% of the experimentally veri®ed AP-1, NFAT, and GATA-3 sites (Loots et al. 2002) . We employed rVISTA to identify putative TFBS across this region and localized 25 of the SNPs generated in CNS within these sites. Of these 25 SNPs, 19 were located in the four base pair core of the putative TFBS, indicating that these SNPs might be functionally important (Table 1c) .
In this 1-Mb region, ®ve (10%) of the CNS identi®ed have been experimentally shown to impact on gene expression, whereas only one (2%) known silencer found in the 3¢UTR of the IL4 gene (Kubo et al. 1997) was not identi®ed by human/ mouse sequence conservation. The observation that approximately 10% of the CNS have been experimentally veri®ed supports our sequence-based strategy for de®ning potential gene regulatory elements. Of the 28 SNPs discovered in the CNS, 25 can be further prioritized as gene regulatory SNPs based on their location in evolutionarily conserved TFBS. This study, using currently available (human and mouse genomic sequence) databases, identi®ed 25 selectively neutral, putative regulatory SNPs. These SNPs, localized to a 1-Mb region of the genome to which several common quantitative The SNP data were partitioned into fragments containing three and nine SNPs, and for each fragment, pairwise comparisons of adjacent SNPs were calcluated by using ARLEQUIN. (All pairwise comparisons were not calculated owing to computational constraints.) The EM algorithm assumes Hardy-Weinberg equilibrium for the SNP allele frequencies, and the rejection of the test could also be due to departure from HardyWeinberg equilibrium. (Continued on next page.) disorders have been mapped [e.g., asthma (Marsh et al. 1994) , in¯ammatory bowel disease (Rioux et al. 2000) ], are a useful resource for direct-association or linkage-disequilibrium analyses.
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